Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delayed interval debulking surgery after neoadjuvant chemotherapy in advanced ovarian cancer
RBR-3y869jPhase 2Recruiting
- Sponsor
- Vanessa da Costa Miranda
- Start
- Sep 2019
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of carboplatin and paclitaxel in ovarian cancer, fallopian tube cancer (PFTC) and primary peritoneal cancer (PPC) (2 arms), sponsored by Vanessa da Costa Miranda. Started Sep 2019; status: recruiting.
02
Drugs
carboplatinpaclitaxel
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on RBR-3y869j.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3y869j.